Skip to main content

Advertisement

SpringerLink
Log in

Anticancer compounds from cyanobacterium Lyngbya species: a review

  • Review Paper
  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

The use of synthetic anticancer drugs and other methods followed in cancer therapy have several side effects; and ineffective methods or drugs give a way to the emergence of drug resistant cancer cells, with the intrinsic metastasis as the aftermath. Anticancer efficacy of many cyanobacterial compounds has been claimed in literature. This review considers 144 compounds isolated and characterized from seven species of the non-nitrogen fixing filamentous cyanobacterium Lyngbya, as the source of antineoplastic agents, which have been screened primarily with cancer cell lines. Structure and information of Lyngbya compounds were retrieved from databases, PubChem, ChemSpider and ChEBI. Information and clinical status of Lyngbya compounds are summarized, and those might be the future anticancer drugs for drug-resistant cancer cells even, as complementary/adduct drugs, if pursued thoroughly in pharmacology and pharmaceutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • An T, Krishnaswamy T, Kumar S, Wang M, Liu L, Lay J Jr, Liyanage R, Berry J, Gantar M, Marks V, Gawley RE, Rein KS (2007) Structures of pahayokolides A and B, two cyclic peptides from a Lyngbya sp. J Nat Prod 70:730–735

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Anonymous (2011) Brentuximab vedotin. Drugs R D 11:85–95. doi: 10.2165/11591070-000000000-00000

  • Anonymous (2015) http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm. Assessed 09 May 2015

  • Bhatnagar I, Kim S-K (2010) Immense essence of excellence: marine microbial bioactive compounds. Mar Drugs 8:2673–2701

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Blokhin AV, Yoo H-D, Geralds RS, Nagle DG, Gerwick WH, Hamel E (1995) Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogs. Mol Pharmacol 48:523–531

    CAS  PubMed  Google Scholar 

  • Bouchard H, Viskov C, Garcia-Echeverria C (2014) Antibody-drug conjugates—a new wave of cancer drugs. Bioorg Med Chem Lett 24:5357–5363

    Article  CAS  PubMed  Google Scholar 

  • Cao Z, Gerwick WH, Murray TF (2010) Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 α subunits. BMC Neurosci 11:154. doi:10.1186/1471-2202-11-154

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Catassi A, Cesario A, Arzani D, Menichini P, Alama A, Bruzzo C, Imperatori A, Rotolo N, Granone P, Russo P (2006) Characterization of apoptosis induced by marine natural products in non small cell lung cancer A549 cells. Cell Mol Life Sci 63:2377–2386

    Article  CAS  PubMed  Google Scholar 

  • Chang TT, More SV, Lu IH, Hsu JC, Chen TJ, Jen YC, Lu CK, Li WS (2011) Isomalyngamide A, A-1 and their analogs suppress cancer cell migration in vitro. Eur J Med Chem 46:3810–3819

    Article  CAS  PubMed  Google Scholar 

  • Cheung MY, Liang S, Lee J (2013) Toxin-producing cyanobacteria in freshwater: a review of the problems, impact on drinking water safety, and efforts for protecting public health. J Microbiol 51:1–10

    Article  CAS  PubMed  Google Scholar 

  • Chlipala GE, Pham HT, Nguyen VH, Krunic A, Shim SH, Soejarto DD, Orjala J (2010) Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J Nat Prod 73:784–787

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Costa M, Costa-Rodrigues J, Fernandes MH, Barros P, Vasconcelos V, Martins R (2012) Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis. Mar Drug 10:2181–2207

    Article  CAS  Google Scholar 

  • Dash NP, Kumar A, Singh PK (2015) Cyanobacteria, pesticides and rice interaction. Biodivers Conserv 24:955–1005

    Google Scholar 

  • Davies-Coleman M, Dzeha TM, Gray CA, Hess S, Pannell LK, Hendricks DT, Arendse CE (2003) Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula. J Nat Prod 66:712–715

    Article  CAS  PubMed  Google Scholar 

  • de Arruda M, Cocchiaro CA, Nelson CM, Grinnell CM, Janssen B, Haupt A, Barlozzari T (1995) LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. Cancer Res 55:3085–3092

    PubMed  Google Scholar 

  • Dixit RB, Suseela MR (2013) Cyanobacteria: potential candidates for drug discovery. Antonie van Leeuwen 103:947–961

    Article  CAS  Google Scholar 

  • Dobretsov S, Abed RMM, Al Maskari SMS, Al Sabahi JN, Victor R (2011) Cyanobacterial mats from hot springs produce antimicrobial compounds and quorum-sensing inhibitors under natural conditions. J Appl Phycol 23:983–993

    Article  CAS  Google Scholar 

  • Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD (2003) Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nat Biotechnol 21:778–784

    Article  CAS  PubMed  Google Scholar 

  • Edwards DJ, Marquez BL, Nogle LM, McPhail K, Goeger DE, Roberts MA, Gerwick WH (2004) Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem Biol 11:817–833

    Article  CAS  PubMed  Google Scholar 

  • Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, Rejniak SX, Gordon KA, DeBlanc R, Toki BE, Law CL, Doronina SO, Siegall CB, Senter PD, Wahl AF (2003) cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity. Blood 102:1458–1465

  • Galhano V, de Figueiredo DR, Alves A, Correia A, Pereira MJ, Laranjo JG, Peixoto F (2011) Morphological, biochemical and molecular characterization of Anabaena, Aphanizomenon and Nostoc strains (Cyanobacteria, Nostocales) isolated from Portuguese freshwater habitats. Hydrobiologia 663:187–203

    Article  CAS  Google Scholar 

  • Gerwick WH, Proteau PJ, Nagle DG, Hamel E, Blokhin A, Slate DL (1994) Structure of curacin A, a novel antimitotic, antiproliferative, and brine shrimp toxic natural product from the marine cyanobacterium Lyngbya majuscula. J Org Chem 59:1243–1245

    Article  CAS  Google Scholar 

  • Gromicho M, Dinis J, Magalhães M, Fernandes AR, Tavares P, Laires A, Rueff J, Rodrigues AS (2011) Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1. Leuk Lymphom 52:1980–1990

    Article  CAS  Google Scholar 

  • Gross H, McPhail KL, Goeger DE, Valeriote FA, Gerwick WH (2010) Two cytotoxic stereoisomers of malyngamide C, 8-epi-malyngamide C and 8-O-acetyl-8-epi-malyngamide C, from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 71:1729–1735

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gunasekera SP, Ross C, Paul VJ, Matthew S, Luesch H (2008) Dragonamides C and D, linear lipopeptides from the marine cyanobacterium brown Lyngbya polychroa. J Nat Prod 71:887–890

    Article  CAS  PubMed  Google Scholar 

  • Gunasekera SP, Owle CS, Montaser R, Luesch H, Paul VJ (2011) Malyngamide 3 and cocosamides A and B from the marine cyanobacterium Lyngbya majuscula from Cocos Lagoon, Guam. J Nat Prod 74:871–876

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gutierrez M, Suyama TL, Engene N, Wingerd JS, Matainaho T, Gerwick WH (2008) Apratoxin D, a potent cytotoxic cyclodepsipeptide from Papua New Guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J Nat Prod 71:1099–1103

    Article  CAS  PubMed  Google Scholar 

  • Han B, McPhail KL, Ligresti A, Di Marzo V, Gerwick WH (2003) Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J Nat Prod 66:1364–1368

    Article  CAS  PubMed  Google Scholar 

  • Han B, Goeger D, Maier CS, Gerwick WH (2005) The wewakpeptins, cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J Org Chem 70:3133–3139

    Article  CAS  PubMed  Google Scholar 

  • Han B, Gross H, Goeger DE, Mooberry SL, Gerwick WH (2006) Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J Nat Prod 69:572–575

    Article  CAS  PubMed  Google Scholar 

  • Hochhaus A, Erben P, Ernst T, Mueller M (2007) Resistance to targeted therapy in chronic myelogenous leukemia. Semin Hematol 44:S15–S24

    Article  CAS  PubMed  Google Scholar 

  • Hummel G, Reineke U, Reimer U (2006) Translating peptides into small molecules. Mol BioSyst 2:499–508

    Article  PubMed  Google Scholar 

  • Jaiswal P, Prasanna R, Singh PK (2005) Isolation and screening of rice field cyanobacteria exhibiting algicidal activity. Asian J Microbiol Biotechnol Environ Sci 7:367–373

    Google Scholar 

  • Jaiswal P, Prasanna R, Singh PK (2008) Cyanobacterial bioactive molecules—an overview of their “cidal” properties. Can J Microbiol 54:701–717

    Article  CAS  PubMed  Google Scholar 

  • Jiménez JI, Scheuer PJ (2001) New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J Nat Prod 64:200–203

    Article  PubMed  Google Scholar 

  • Joo SH (2012) Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther (Seoul) 20:19–26

    Article  CAS  Google Scholar 

  • Klein D, Braekman JC, Daloze D, Hoffmann L, Castillo G, Demoulin V (1999) Lyngbyapeptin A, a modi®ed tetrapeptide from Lyngbya bouillonii (Cyanophyceae). Tetrahedron Lett 40:695–696

    Article  CAS  Google Scholar 

  • Kulasooriya SA (2011) Cyanobacteria: pioneers of planet earth. Ceylon J Sci (BioSci) 40:71–88

    Google Scholar 

  • Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H (2009) Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J Med Chem 52:5732–5747

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • LePage KT, Goeger D, Yokokawa F, Asano T, Shioiri T, Gerwick WH, Murray TF (2005) The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol Lett 158:133–139

    Article  CAS  PubMed  Google Scholar 

  • Li L (2010) Rein KS (2010) New Peptides Isolated from Lyngbya species: a review. Mar Drugs 8:1817–1837

    Article  Google Scholar 

  • Li D, Poon KA, Yu SF, Dere R, Go M, Lau J, Zheng B, Elkins K, Danilenko D, Kozak KR, Chan P, Chuh J, Shi X, Nazzal D, Fuh F, McBride J, Ramakrishnan V, de Tute R, Rawstron A, Jack AS, Deng R, Chu YW, Dornan D, Williams M, Ho W, Ebens A, Prabhu S, Polson AG (2013) DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma. Mol Cancer Ther 12:1255–1265

    Article  CAS  PubMed  Google Scholar 

  • Loffet A (2002) Peptides as drugs: is there a market? J Pept Sci 8:1–7

    Article  CAS  PubMed  Google Scholar 

  • Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL (2000) Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 63:611–615

    Article  CAS  PubMed  Google Scholar 

  • Luesch H, Pangilinan R, Yoshida WY, Moore RE, Paul VJ (2001) Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 64:304–307

    Article  CAS  PubMed  Google Scholar 

  • Luesch H, Yoshida WY, Moore RE, Paul VJ (2002) New apratoxins of marine cyanobacterial origin from Guam and Palau. Bioorg Med Chem 10:1973–1978

    Article  CAS  PubMed  Google Scholar 

  • Ma D, Zou B, Cai G, Hu X, Liu JO (2006) Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities. Chemistry 12:7615–7626

    Article  CAS  PubMed  Google Scholar 

  • Ma´rquez B, Verdier-Pinard P, Hamel E, Gerwick WH (1998) Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 49:2387–2389

    Article  Google Scholar 

  • MacMillan JB, Molinski TF (2002) Caylobolide A, a unique 36-membered macrolactone from a Bahamian Lyngbya majuscula. Org Lett 4:1535–1538

    Article  CAS  PubMed  Google Scholar 

  • Malloy KL, Villa FA, Engene N, Matainaho T, Gerwick L, Gerwick WH (2011) Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a papua new guinea marine cyanobacterium. J Nat Prod 74:95–98

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Marks RS, Graham DL, Sloan JA, Hillman S, Fishkoff S, Krook JE, Okuno SH, Mailliard JA, Fitch TR, Addo F (2003) Phase II study of the dolastatin 15 analogue Lu 103793 in the treatment of advanced non-small-cell lung cancer. Am J Clin Oncol 26:336–337

    CAS  PubMed  Google Scholar 

  • Martins RF, Ramos MF, Herfindal L, Sousa JA, Skarven K, Vasconcelos VM (2008) Antimicrobial and cytotoxic assessment of marine cyanobacteria—Synechocystis and Synechococcus. Mar Drugs 6:1–11

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Matthew S, Ross C, Rocca JR, Paul VJ, Luesch H (2007) Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. J Nat Prod 70:124–127

    Article  CAS  PubMed  Google Scholar 

  • Matthew S, Schupp PJ, Luesch H (2008) Apratoxin E, a cytotoxic peptolide from a Guamanian collection of the marine cyanobacterium Lyngbya bouillonii. J Nat Prod 71:1113–1116

    Article  CAS  PubMed  Google Scholar 

  • Matthew S, Paul VJ, Luesch H (2009a) Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium Lyngbya confervoides. Planta Med 75:528–533

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Matthew S, Paul VJ, Luesch H (2009b) Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides. Phytochemistry 70:2058–2063

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McPhail KL, Correa J, Linington RG, Gonza´lez J, Ortega-Barrı´a E, Capson TL, Gerwick WH (2007) Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscule. J Nat Prod 70:984–988

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Medina RA, Goeger DE, Hills P, Mooberry SL, Huang N, Romero LI, Ortega-Barría E, Gerwick WH, McPhail KL (2008) Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. J Am Chem Soc 130:6324–6325

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mita AC, Hammond LA, Bonate PL, Weiss G, McCreery H, Syed S, Garrison M, Chu QS, DeBono JS, Jones CB, Weitman S, Rowinsky EK (2006) Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third generation dolastatin-15 analogues, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors. Clin Cancer Res 12:5207–5215

    Article  CAS  PubMed  Google Scholar 

  • Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: promising resources for cancer drug discovery. Antican Agent Med Chem 12:49–75

    Article  CAS  Google Scholar 

  • Montaser R, Abboud KA, Paul VJ, Luesch H (2011) Pitiprolamide, a proline-rich dolastatin 16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam. J Nat Prod 74:109–112

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Moore RE, Corbett TH, Patterson GML, Valeriote FA (1996) The search for new antitumor drugs from blue-green algae. Current Pharm Design 2:317–330

    CAS  Google Scholar 

  • Mynderse JS, Moore RE, Kashiwagi M, Norton TR (1977) Antileukemia activity in the Oscillatoriaceae: isolation of debromoaplysiatoxin from Lyngbya. Science 196:538–540

    Article  CAS  PubMed  Google Scholar 

  • Natarajan C, Gupta V, Kumar K, Prasanna R (2013) Molecular characterization of a fungicidal endoglucanase from the cyanobacterium Calothrix elenkinii. Biochem Genet 51:766–779

    Article  CAS  PubMed  Google Scholar 

  • Nautiyal J, Kanwar SS, Yingjie YuY, Majumdar APN (2011) Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. J Mol Signal 6:7. doi:10.1186/1750-2187-6-7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Newman DJ, Cragg GM (2004) Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod 67:1216–1238

    Article  CAS  PubMed  Google Scholar 

  • Newman DJ, Cragg GM (2014) Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Mar Drugs 12:255–278

    Article  PubMed Central  PubMed  Google Scholar 

  • Nogle LM, Gerwick WH (2002) Isolation of four new cyclic depsipeptides, antanapeptins A-D, and dolastatin 16 from a Madagascan collection of Lyngbya majuscula. J Nat Prod 65:21–24

    Article  CAS  PubMed  Google Scholar 

  • Nogle LM, Gerwick WH (2003) Diverse secondary metabolites from a Puerto Rican collection of Lyngbya majuscula. J Nat Prod 66:217–220

    Article  CAS  PubMed  Google Scholar 

  • Nogle LM, Okino T, Gerwick WH (2001) Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 64:983–985

    Article  CAS  PubMed  Google Scholar 

  • Oftedal L, Selheim F, Wahlsten M, Sivonen K, Døskeland SO, Herfindal L (2010) Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes. Mar Drugs 8:2659–2672

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Perez EA, Hillman DW, Fishkin PA, Krook JE, Tan WW, Kuriakose PA, Alberts SR, Dakhil SR (2005) Phase II trial of dolastatin-10 in patients with advanced breast cancer. Invest New Drug 23:257–261

    Article  CAS  Google Scholar 

  • Pettit GR, Hogan F, Xu JP, Tan R, Nogawa T, Cichacz Z, Pettit RK, Du J, Ye QH, Cragg GM, Herald CL, Hoard MS, Goswami A, Searcy J, Tackett L, Doubek DL, Williams L, Hooper JN, Schmidt JM, Chapuis JC, Tackett DN, Craciunescu F (2008) Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms (1a,). J Nat Prod 71:438–444

    Article  CAS  PubMed  Google Scholar 

  • Phillips AC, Boghaert ER, Vaidya KS Ansell PJ, Shalinsky DR, Zhang Y, Voorbach MJ, Mudd S, Holen KD, Humerickhouse RA, Reilly EB (2013) ABT-414: an anti-EGFR antibody-drug conjugate as a potential therapeutic for the treatment of patients with squamous cell tumors. In proceedings of the 25th EORTC-NCI-AACR symposium on Mol Cancer Ther 12; A250. doi:10.1158/1535-7163.TARG-13-A250

  • Ramaswamy AV, Sorrels CM, Gerwick WH (2007) Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 70:1977–1986

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Meizoso I, Jaime L, Santoyo S, Cifuentes A, García-Blairsy RG, Señoráns FJ, Ibáñez E (2008) Pressurized fluid extraction of bioactive compounds from Phormidium species. J Agric Food Chem 56:3517–3523

    Article  CAS  PubMed  Google Scholar 

  • Sainis I, Fokas D, Vareli K, Tzakos AG, Kounnis V, Briasoulis E (2010) Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs. Mar Drugs 8:629–657

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Simmons TL, Andrianasolo E, McPhail K, Flatt P, Gerwick WH (2005) Marine natural products as anticancer drugs. Mol Can Ther 4:333–342

    CAS  Google Scholar 

  • Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH (2009) Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. J Nat Prod 72:1011–1016

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Singh RK, Tiwari SP, Rai AK, Mohapatra TM (2011) Cyanobacteria: an emerging source for drug discovery. J Antibiot 64:401–412

    Article  CAS  PubMed  Google Scholar 

  • Soria-Mercado IE, Pereira A, Cao Z, Murray TF, Gerwick WH (2009) Alotamide A, a novel neuropharmacological agent from the marine cyanobacterium Lyngbya bouillonii. Org Lett 11:4704–4707

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Tabuchi Y, Matsuoka J, Gunduz M, Imada T, Ono R, Ito M, Motoki T, Yamatsuji T, ShirakawaY Takaoka M, Haisa M, Tanaka N, Kurebayashi J, Jordan VC, Naomoto Y (2009) Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Int J Oncol 34:313–319

    CAS  PubMed  Google Scholar 

  • Tan LT (2007) Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry 68:954–979

    Article  CAS  PubMed  Google Scholar 

  • Taniguchi M, Nunnery JK, Engene N, Esquenazi E, Byrum T, Dorrestein PC, Gerwick WH (2010) Palmyramide A, a cyclic depsipeptide from a palmyra atoll collection of the marine cyanobacterium Lyngbya majuscula. J Nat Prod 73:393–398

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Taori K, Matthew S, Rocca JR, Paul VJ, Luesch H (2007) Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp. J Nat Prod 70:1593–1600

    Article  CAS  PubMed  Google Scholar 

  • Taori K, Paul VJ, Luesch H (2008) Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp. J Nat Prod 71:1625–1629

    Article  CAS  PubMed  Google Scholar 

  • Teruya T, Sasaki H, Kitamura K, Nakayama T, Suenaga K (2009a) Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya sp. Org Lett 11:2421–2424

    Article  CAS  PubMed  Google Scholar 

  • Teruya T, Sasaki H, Fukazawa H, Suenaga K (2009b) Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity. Org Lett 11:5062–5065

    Article  CAS  PubMed  Google Scholar 

  • Tidgewell K, Engene N, Byrum T, Media J, Doi T, Valeriote FA, Gerwick WH (2010) Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. Chem BioChem 11:1458–1466

    CAS  Google Scholar 

  • Tripathi A, Puddick J, Prinsep MR, Lee PPF, Tan LT (2009a) Hantupeptin A, a cytotoxic cyclic depsipeptide from a Singapore collection of Lyngbya majuscula. J Nat Prod 72:29–32

    Article  CAS  PubMed  Google Scholar 

  • Tripathi A, Puddick J, Prinsep MR, Lee PPF, Tan LT (2009b) Hantupeptins B and C, cytotoxic cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 72:29–32

    CAS  Google Scholar 

  • Tripathi A, Puddick J, Prinsep MR, Rottmann M, Chan KP, Chen DY, Tan LT (2011) Lagunamide C, a cytotoxic cyclodepsipeptide from the marine cyanobacterium Lyngbya majuscula. Phytochemistry 72:2369–2375

    Article  CAS  PubMed  Google Scholar 

  • Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15:40–56

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Ma D, Olson WC, Heston WD (2011) In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen. Mol Cancer Ther 10:1728–1739

    Article  CAS  PubMed  Google Scholar 

  • Watanabe J, Minami M, Kobayashi M (2006) Antitumor activity of TZT-1027 (soblidotin). Anticancer Res 26:1973–1981

    CAS  PubMed  Google Scholar 

  • White JD, Xu Q, Lee CS, Valeriote FA (2004) Total synthesis and biological evaluation of kalkitoxin, a cytotoxic metabolite of the cyanobacterium Lyngbya majuscula. Org Biomol Chem 2:2092–2102

    Article  CAS  PubMed  Google Scholar 

  • Williams PG, Yoshida WY, Moore RE, Paul VJ (2002) Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides. J Nat Prod 65:29–31

    Article  CAS  PubMed  Google Scholar 

  • Williams PG, Yoshida WY, Quon MK, Moore RE, Paul VJ (2003) Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp. J Nat Prod 66:651–654

    Article  CAS  PubMed  Google Scholar 

  • Wipf P, Reeves JT, Day BW (2004) Chemistry and biology of curacin A. Curr Pharm Des 10:1417–1437

    Article  CAS  PubMed  Google Scholar 

  • Wrasidlo W, Mielgo A, Torres VA, Barbero S, Stoletov K, Suyama TL, Klemke RL, Gerwick WH, Carson DA, Stupack DG (2008) The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc Natl Acad Sci USA 105:2313–2318

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yardley DA, Weaver R, Melisko ME, Saleh MN, Arena FP, Forero A, Cigler T, Stopeck A, Citron D, Oliff I, Bechhold R, Loutfi R, Garcia A, Crowley E, Green J, Yellin MJ, Davis TA, Vahdat LT (2012) A randomized phase 2 study of the antibody-drug donjugate CDX-011 in advanced GPNMB-over-expressing breast cancer: the emerge study. In: Proceedings of the CTRC-AACR San Antonio breast cancer symposium, San Antonio, TX, USA, 4–8 December

  • Yoo HD, Gerwick WH (1995) Curacins B and C, new antimitotic natural products from the marine cyanobacterium Lyngbya majuscula. J Nat Prod 58:1961–1965

    Article  CAS  Google Scholar 

  • Zou B, Long K, Ma DW (2005) Total synthesis and cytotoxicity studies of a cyclic depsipeptide with proposed structure of palauamide. Org Lett 7:4237–4240

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Research Laboratory, IMS & Sum Hospital, Siksha ‘O’ Anusandhan University, Kalinga Nagar, Bhubaneswar, 751003, Odisha, India

    Shasank S. Swain & Rabindra N. Padhy

  2. Department of Botany, Banaras Hindu University (BHU), Varanasi, 221005, UP, India

    Pawan K. Singh

Authors
  1. Shasank S. Swain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rabindra N. Padhy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pawan K. Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rabindra N. Padhy.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Swain, S.S., Padhy, R.N. & Singh, P.K. Anticancer compounds from cyanobacterium Lyngbya species: a review. Antonie van Leeuwenhoek 108, 223–265 (2015). https://doi.org/10.1007/s10482-015-0487-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10482-015-0487-2

Keywords

Search

Navigation